| Daniela Prodanovic, MD | |
|
189 Quincy St, Brockton, MA 02302-2926 | |
| (508) 588-6700 | |
| (508) 584-3010 |
| Full Name | Daniela Prodanovic |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 39 Years |
| Location | 189 Quincy St, Brockton, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104859628 | NPI | - | NPPES |
| 2107651 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 223731 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beth Israel Deaconess Hospital Plymouth | Plymouth, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jordan Physician Associates Inc | 1254321086 | 153 |
News Archive
Scientists at City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, have developed a novel, noninvasive liquid biopsy test for detecting lymph node metastasis in individuals with high-risk T1 colorectal carcinoma.
Stem Cell Therapy International Inc. (OTCBB: SCII) announced that it has signed an agreement with Histostem Ltd. of South Korea ("Histostem"), for the exclusive, worldwide rights to the distribution of the Company's existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for purchase only in Korea, SteMixx received approval last month from the Korean FDA as an effective cosmetic for the treatment of aging skin.
A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest at UMass Medical School to harness the power of DNA vaccines in addressing a major global health threat.
Nearly twelve years ago, Michigan voters approved the use of medical cannabis by residents with certain health conditions. A year and a half ago, they voted to approve its use by all adults, for any reason.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, including the investigational drug ILUVIEN for the treatment of Diabetic Macular Edema, today announced month 36, top-line readout results for the FAME Study prepared by its licensee, Alimera Sciences.
› Verified 6 days ago
| Entity Name | Jordan Physician Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538145131 PECOS PAC ID: 1254321086 Enrollment ID: O20040514000167 |
News Archive
Scientists at City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, have developed a novel, noninvasive liquid biopsy test for detecting lymph node metastasis in individuals with high-risk T1 colorectal carcinoma.
Stem Cell Therapy International Inc. (OTCBB: SCII) announced that it has signed an agreement with Histostem Ltd. of South Korea ("Histostem"), for the exclusive, worldwide rights to the distribution of the Company's existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for purchase only in Korea, SteMixx received approval last month from the Korean FDA as an effective cosmetic for the treatment of aging skin.
A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest at UMass Medical School to harness the power of DNA vaccines in addressing a major global health threat.
Nearly twelve years ago, Michigan voters approved the use of medical cannabis by residents with certain health conditions. A year and a half ago, they voted to approve its use by all adults, for any reason.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, including the investigational drug ILUVIEN for the treatment of Diabetic Macular Edema, today announced month 36, top-line readout results for the FAME Study prepared by its licensee, Alimera Sciences.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniela Prodanovic, MD 189 Quincy St, Brockton, MA 02302-2926 Ph: (508) 588-6700 | Daniela Prodanovic, MD 189 Quincy St, Brockton, MA 02302-2926 Ph: (508) 588-6700 |
News Archive
Scientists at City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, have developed a novel, noninvasive liquid biopsy test for detecting lymph node metastasis in individuals with high-risk T1 colorectal carcinoma.
Stem Cell Therapy International Inc. (OTCBB: SCII) announced that it has signed an agreement with Histostem Ltd. of South Korea ("Histostem"), for the exclusive, worldwide rights to the distribution of the Company's existing SteMixx line of stem cell based cosmetic products, as well as future products under development. Previously available for purchase only in Korea, SteMixx received approval last month from the Korean FDA as an effective cosmetic for the treatment of aging skin.
A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest at UMass Medical School to harness the power of DNA vaccines in addressing a major global health threat.
Nearly twelve years ago, Michigan voters approved the use of medical cannabis by residents with certain health conditions. A year and a half ago, they voted to approve its use by all adults, for any reason.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, including the investigational drug ILUVIEN for the treatment of Diabetic Macular Edema, today announced month 36, top-line readout results for the FAME Study prepared by its licensee, Alimera Sciences.
› Verified 6 days ago
Louis D. Gottlieb, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 680 Centre St, Managed Care, Brockton, MA 02302 Phone: 508-941-7065 Fax: 508-941-6373 | |
Gloria Ibarra, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 63 Main St, Brockton, MA 02301 Phone: 508-559-6699 Fax: 508-559-5073 | |
Elsie Varughese, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 63 Main St, Brockton, MA 02301 Phone: 508-559-6699 Fax: 508-583-4649 | |
Jane G Butlin, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1 Pearl St, Suite 2200, Brockton, MA 02301 Phone: 508-897-6051 Fax: 508-897-6096 | |
Jacob Mandell, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 680 Centre St, Brockton Hospital, Brockton, MA 02302 Phone: 508-941-7150 | |
Jolly Abeskheron, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1 Pearl St, Suite 1000, Brockton, MA 02301 Phone: 508-897-6060 Fax: 508-897-6063 | |
Xin He, Gastroenterology Medicare: Medicare Enrolled Practice Location: 110 Liberty St, Brockton, MA 02301 Phone: 508-894-0400 |